Adaptive COVID-19 Treatment Trial 2 (ACTT-II)
Condition: COVID-19 Interventions: Other: Placebo; Drug: Remdesivir; Drug: Baricitinib Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials